| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | |||
| Gross Profit | $ 14.69M | $ 15.56M | $ 16.19M |
| Operating Income | $ 5.45M | $ 3.94M | $ 2.12M |
| EBITDA | $ 7.32M | $ 6.02M | $ 3.81M |
| Net Income | $ 2.74M | $ 1.45M | $ 1.47M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― |
| Total Assets | $ 62.73M | $ 53.81M | $ 42.66M |
| Total Debt | $ 33.37M | $ 29.55M | $ 25.17M |
| Net Debt | $ 14.42M | $ 22.12M | $ 22.04M |
| Total Liabilities | $ 41.54M | $ 38.38M | $ 32.37M |
| Stockholders' Equity | $ ― | $ ― | $ ― |
| Cash Flow | |||
| Free Cash Flow | $ 4.78M | $ -307.77K | $ 5.42M |
| Operating Cash Flow | $ 8.39M | $ 2.66M | $ 6.12M |
| Investing Cash Flow | |||
| Financing Cash Flow |
AiDa Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.